Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.27 -0.20 (-2.36%)
At close: Sep 29, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Total Debt (2011 - 2026)

Updated

Biocryst Pharmaceuticals (BCRX) reported Total Debt of $439.21 million for Q2 2026, up 57.7% from $278.54 million a year earlier and up 0.8% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Total Debt (2011 - 2026) Analysis & Trends

At the end of FY2025, Biocryst Pharmaceuticals posted Total Debt of $38.46 million, down 88.9% from FY2024.

  • Total Debt has a five-year compound annual growth rate of -23.8% (FY2020 to FY2025).
  • By year, Total Debt came in at $347.55 million in FY2024 (+6.3%), $326.8 million in FY2023 (+41.1%), $231.62 million in FY2022 (+70.2%) and $136.08 million in FY2021 (-9.1%).
  • The Q2 2026 figure ranks as the highest quarterly Total Debt in data going back to Q2 2011.
  • Year over year, Total Debt gained in five of the last eight quarters, with an average decline of 3.9%.
  • The high point for year-over-year Total Debt in five years was Q3 2021 (growth of 113.4%); the low point was Q4 2025 (a decline of 88.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $435.51 million (Q1 2026), $38.46 million (Q4 2025) and $232.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Biocryst Pharmaceuticals 2.16 Bn 1.08 Bn 214.41 Mn 439.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 439.21 Mn
Mar 31, 2026 435.51 Mn
Dec 31, 2025 38.46 Mn
Sep 30, 2025 232.05 Mn
Jun 30, 2025 278.54 Mn
Mar 31, 2025 349.72 Mn
Dec 31, 2024 347.55 Mn
Sep 30, 2024 347.33 Mn
Jun 30, 2024 342.80 Mn
Mar 31, 2024 334.51 Mn
Dec 31, 2023 326.80 Mn
Sep 30, 2023 298.00 Mn
Jun 30, 2023 293.18 Mn
Mar 31, 2023 232.52 Mn
Dec 31, 2022 231.62 Mn
Sep 30, 2022 223.87 Mn
Jun 30, 2022 144.52 Mn
Mar 31, 2022 140.24 Mn
Dec 31, 2021 136.08 Mn
Sep 30, 2021 162.05 Mn
API Access

Biocryst Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=BCRX&period=max&api_key=YOUR_API_KEY